Clinical trials
27 results
Applied filters
Monitoring and auditing clinical trials
29 April 2026An overview of the Sponsor Pharmacy's responsibilities for monitoring and auditing clinical trial locations.
Closing clinical trials
29 April 2026Sponsor pharmacy responsibilities during trial closure and the final monitoring visit
Assuring the supply chain for IMPs and NIMPs
29 April 2026Sponsor pharmacy role regarding the supply assurance of Investigational Medicinal Products (IMPs) and Non-Investigational Medicinal Products (NIMPs) in CTIMPs.
Feasibility and setting up of clinical trials at delivery locations
29 April 2026An overview of the Sponsor Pharmacy's responsibilities during setup of a clinical trial in a delivery organisation or location.
Risk assessing Investigational Medicinal Products (IMPs)
29 April 2026Sponsor pharmacy responsibilities when assessing the risk associated with CTIMPs.
Additional considerations for single or multi-centre trials
29 April 2026Ensure the correct process is followed depending on whether it is a single or multi-centre trial sponsored by an NHS organisation.
Constructing a pharmacy manual for clinical trials
29 April 2026Sponsor pharmacy should construct a pharmacy manual when required by the sponsor to facilitate IMP and NIMP management by the different delivery location sites.
Updated clinical trials regulation: implementation considerations
26 February 2026An SPS Quality Assurance learning event on understanding the updated clinical trials regulation and practical considerations for pharmacy clinical trials sites.
Ex-vivo GMO gene therapy medicinal products
13 February 2026This document outlines key areas for focus of pharmacy expertise prior to an organisation implementing ex-vivo genetically modified organism (GMO) gene therapy.
In-vivo GMO gene therapy medicinal products
13 February 2026This document outlines key areas for focus of pharmacy expertise prior to an organisation implementing in-vivo genetically modified organism (GMO) gene therapy.